Drainas A, McIlwain D, Dallas A, Chu T, Delgado-Gonzalez A, Baron M
Nat Biomed Eng. 2025; .
PMID: 39939547
DOI: 10.1038/s41551-025-01349-0.
Hiremath J, Swathi M, Ramamoorthy R, Shijili M, Sharma D, Hemadri D
Virol J. 2025; 22(1):28.
PMID: 39910537
PMC: 11800441.
DOI: 10.1186/s12985-024-02606-5.
Rerolle F, Dey A, Benmarhnia T, Arnold B
Int J Epidemiol. 2024; 53(6).
PMID: 39657980
PMC: 11631194.
DOI: 10.1093/ije/dyae160.
Hay J, Routledge I, Takahashi S
Epidemics. 2024; 49:100806.
PMID: 39647462
PMC: 11649536.
DOI: 10.1016/j.epidem.2024.100806.
Kim K, Vieira M, Gouma S, Weirick M, Hensley S, Cobey S
Influenza Other Respir Viruses. 2024; 18(11):e70033.
PMID: 39501522
PMC: 11538025.
DOI: 10.1111/irv.70033.
Model-based estimates of age-structured SARS-CoV-2 epidemiology in households.
Toth D, Sheets T, Beams A, Ahmed S, Seegert N, Love J
BMC Public Health. 2024; 24(1):2965.
PMID: 39455984
PMC: 11515260.
DOI: 10.1186/s12889-024-20308-z.
A serological survey of COVID-19 among predominantly aboriginal residents of a tourist island in southern Thailand.
Sripaew S, Yasharad K, Rahari D, Feng W, Qian Z, Thanh H
Trop Med Health. 2024; 52(1):57.
PMID: 39232844
PMC: 11373474.
DOI: 10.1186/s41182-024-00617-0.
Impact of waning immunity against SARS-CoV-2 severity exacerbated by vaccine hesitancy.
Saad-Roy C, Morris S, Boots M, Baker R, Lewis B, Farrar J
PLoS Comput Biol. 2024; 20(8):e1012211.
PMID: 39102402
PMC: 11299835.
DOI: 10.1371/journal.pcbi.1012211.
Identification of methodological issues regarding direct impact indicators of COVID-19: a rapid scoping review on morbidity, severity and mortality.
Garriga C, Valero-Gaspar T, Rodriguez-Blazquez C, Diaz A, Bezzegh P, Dankova S
Eur J Public Health. 2024; 34(Supplement_1):i3-i10.
PMID: 38946440
PMC: 11215319.
DOI: 10.1093/eurpub/ckae072.
Feasibility and acceptability of collecting dried blood spots (DBS) from children after vaccination during supplementary immunization activities to estimate measles and rubella seroprevalence.
Carcelen A, Prosperi C, Hamahuwa M, Kapungu K, Chongwe G, Mwansa F
PLOS Glob Public Health. 2024; 4(6):e0002985.
PMID: 38941295
PMC: 11213301.
DOI: 10.1371/journal.pgph.0002985.
Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies in Healthcare Personnel in El Salvador Prior to Vaccination Campaigns.
Ramirez J, Maliga A, Stewart A, Lino A, Oliva J, Sandoval X
Infect Dis Rep. 2024; 16(3):531-542.
PMID: 38920896
PMC: 11203478.
DOI: 10.3390/idr16030040.
COVID-19 seroprevalence cohort survey among health care workers and their household members in Kinshasa, DR Congo, 2020-2022.
Madinga J, Mbala-Kingebeni P, Nkuba-Ndaye A, Baketana-Kinzonzi L, Matungulu-Biyala E, Mutombo-Lupola P
J Health Popul Nutr. 2024; 43(1):74.
PMID: 38824595
PMC: 11144309.
DOI: 10.1186/s41043-024-00536-0.
The impact of sub-national heterogeneities in demography and epidemiology on the introduction of rubella vaccination programs in Nigeria.
Nakase T, Brownwright T, Okunromade O, Egwuenu A, Ogunbode O, Lawal B
Vaccine. 2024; 42(20):125982.
PMID: 38811269
PMC: 11792317.
DOI: 10.1016/j.vaccine.2024.05.030.
Modeling the Cost of Vaccinating a Measles Zero-Dose Child in Zambia Using Three Vaccination Strategies.
Mak J, Patenaude B, Mutembo S, Pilewskie M, Winter A, Moss W
Am J Trop Med Hyg. 2024; 111(1):121-128.
PMID: 38772386
PMC: 11229634.
DOI: 10.4269/ajtmh.23-0412.
Serological diagnosis of soil-transmitted helminth (Ascaris, Trichuris and hookworm) infections: A scoping review.
Roose S, Vande Velde F, Vlaminck J, Geldhof P, Levecke B
PLoS Negl Trop Dis. 2024; 18(4):e0012049.
PMID: 38574166
PMC: 10994556.
DOI: 10.1371/journal.pntd.0012049.
SARS-CoV-2 seroprevalence among children in Greece during Omicron variant period.
Dimopoulou D, Sotiri D, Kousi D, Loulou G, Raptaki K, Neofytou A
Eur J Pediatr. 2024; 183(5):2491-2499.
PMID: 38478132
DOI: 10.1007/s00431-024-05486-7.
Multimodal Surveillance Model for Enterovirus D68 Respiratory Disease and Acute Flaccid Myelitis among Children in Colorado, USA, 2022.
Messacar K, Matzinger S, Berg K, Weisbeck K, Butler M, Pysnack N
Emerg Infect Dis. 2024; 30(3):423-431.
PMID: 38407198
PMC: 10902548.
DOI: 10.3201/eid3003.231223.
Population measles seroprevalence: Heterogeneity by birth-year cohort.
Santacruz-Sanmartin E, Hincapie-Palacio D, Ochoa J, Buitrago S, Ospina M
J Virus Erad. 2023; 9(4):100352.
PMID: 38046787
PMC: 10692715.
DOI: 10.1016/j.jve.2023.100352.
Correcting for Antibody Waning in Cumulative Incidence Estimation From Sequential Serosurveys.
Kadelka S, Bouman J, Ashcroft P, Regoes R
Am J Epidemiol. 2023; 193(5):777-786.
PMID: 38012125
PMC: 11074712.
DOI: 10.1093/aje/kwad226.
Measures of population immunity can predict the dominant clade of influenza A (H3N2) in the 2017-2018 season and reveal age-associated differences in susceptibility and antibody-binding specificity.
Kim K, Vieira M, Gouma S, Weirick M, Hensley S, Cobey S
medRxiv. 2023; .
PMID: 37961288
PMC: 10635207.
DOI: 10.1101/2023.10.26.23297569.